ArticleClinical and experimental medicine2025
Editorial Expression of Concern: Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.
Kai Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.